American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 733-736 , May 2009

Thrombocytosis in EPO-Treated Dialysis Patients May Be Mediated by EPO Rather Than Iron Deficiency

  • Nosratola D. Vaziri, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Nosratola D. Vaziri, MD, University of California, Irvine, Division of Nephrology and Hypertension, 101 The City Dr, Bldg 53, Rm 125, Rt 81, Orange, CA 92868

  • Image Result

    Effects of high doses of erythropoietin on platelet production, platelet activity, and potential risks of thromboembolism and cardiovascular disease. Abbreviations: [Ca2+]i, intracellular ionized calc

    Effects of high doses of erythropoietin on platelet production, platelet activity, and potential risks of thromboembolism and cardiovascular disease. Abbreviations: [Ca2+]i, intracellular ionized calcium concentration; vWF, von Willebrand factor.

 Originally published online as doi:10.1053/j.ajkd.2008.12.030 on March 23, 2009.

PII: S0272-6386(09)00147-4

doi: 10.1053/j.ajkd.2008.12.030

American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 733-736 , May 2009